Allergic Rhinitis :: FDA may accept Loratadine/Montelukast Tablet for allergic rhinitis
Schering-Plough/Merck Pharmaceuticals (SPM) announced that the New Drug Application filing for loratadine/montelukast has been accepted by the U.S. Food and Drug Administration (FDA) for standard review.